Related Experiment Video
Updated: Dec 27, 2025

14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
24.2K
Primary Progressive Aphasia Education and Support Groups: A Clinical Evaluation
Cathleen Taylor-Rubin1,2,3, Lisa Azizi4, Karen Croot2,3,5
1Speech Pathology Department, War Memorial Hospital, Sydney, New South Wales, Australia.
American Journal of Alzheimer'S Disease and Other Dementias
|February 26, 2020
Summary
Education and support sessions significantly benefit caregivers of individuals with primary progressive aphasia (PPA), improving knowledge, coping strategies, and reducing isolation. These sessions are a valuable part of PPA care.
Area of Science:
- Neurology
- Psychology
- Speech-Language Pathology
Background:
- Primary progressive aphasia (PPA) presents unique challenges for individuals and their caregivers.
- Effective support systems are crucial for managing the emotional and practical aspects of PPA.
Purpose of the Study:
- To evaluate the benefits of a PPA education and support session for people with PPA (pwPPA) and their caregivers.
- To assess the impact of these sessions on caregiver knowledge, emotional well-being, and social support.
Main Methods:
- A study involved 25 participants (12 pwPPA, 13 caregivers) completing pre- and post-session questionnaires.
- Follow-up interviews were conducted with 7 participants (2 pwPPA, 5 caregivers).
- Sessions were led by a speech pathologist and a clinical psychologist.
Main Results:
- Caregivers reported significant improvements in PPA knowledge, mood management strategies, and peer connection after one session.
- Interview themes included reduced isolation, increased support, enhanced coping strategies, and better PPA understanding.
- Caregivers with prior session attendance noted improved well-being and support.
Conclusions:
- PPA education and support group sessions are a valuable component of postdiagnostic care.
- These sessions effectively address the needs of both individuals with PPA and their caregivers.
- Integrating such programs can enhance the comprehensive care framework for PPA.
More Related Videos
Related Concept Videos
Self-Help Support Groups
256
Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
256
Group Therapy
290
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
290
Learning Disabilities
524
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
524
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699

